Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

X4 Pharmaceuticals (XFOR) Shares Repurchased (2023)

X4 Pharmaceuticals (XFOR) has disclosed Shares Repurchased for 1 consecutive years, with $443000.0 as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Shares Repurchased changed N/A year-over-year to $443000.0, compared with a TTM value of $443000.0 through Mar 2023, changed N/A, and an annual FY2021 reading of $2.0 million, changed N/A over the prior year.
  • Shares Repurchased was $443000.0 for Q1 2023 at X4 Pharmaceuticals.
  • Across five years, Shares Repurchased topped out at $443000.0 in Q1 2023 and bottomed at $443000.0 in Q1 2023.